SFJ Pharmaceuticals Inc., a platform for bringing U.S. and European drugs to Japan, has raised $45 million in Series A funding, according to VentureWire. Abingworth Management and Clarus Ventures co-led the round, which was designed to help the company acquire its first products. www.sfj-pharma.com (website not currently active)

Related posts:

  1. Novagali Pharma Raises €15 Million
  2. 7TM Pharma Raises $15 Million
  3. Nitec Pharma Raises $22 Million
  4. Victory Pharma Raises $45 Million
  5. Glide Pharma Raises £2.2 Million